AIMMUNE THERAPEUTICS INC.
AIMMUNE THERAPEUTICS INC.
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: AIMT
ISIN:

Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics — Discovering Underlying Factors of Influence

  • 80

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of L3 Technologies Inc. (NYSE:LLL), The Goldman Sachs Group, Inc. (NYSE:GS), Genuine Parts Company (NYSE:GPC), Bruker Corporation (NASDAQ:BRKR), Omeros Corporation (NASDAQ:OMER), and Aimmune Therapeutics, Inc. (NASDAQ:AIMT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

LLL DOWNLOAD: http://MarketSourceResearch.com/register/?so=LLL
GS DOWNLOAD: http://MarketSourceResearch.com/register/?so=GS
GPC DOWNLOAD: http://MarketSourceResearch.com/register/?so=GPC
BRKR DOWNLOAD: http://MarketSourceResearch.com/register/?so=BRKR
OMER DOWNLOAD: http://MarketSourceResearch.com/register/?so=OMER
AIMT DOWNLOAD: http://MarketSourceResearch.com/register/?so=AIMT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine L3 Technologies Inc. (NYSE:LLL), The Goldman Sachs Group, Inc. (NYSE:GS), Genuine Parts Company (NYSE:GPC), Bruker Corporation (NASDAQ:BRKR), Omeros Corporation (NASDAQ:OMER), and Aimmune Therapeutics, Inc. (NASDAQ:AIMT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed December 31st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

L3 TECHNOLOGIES INC. (LLL) REPORT OVERVIEW

L3 Technologies' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, L3 Technologies reported revenue of $2,519.00MM vs $2,293.00MM (up 9.86%) and analysts estimated basic earnings per share $2.57 vs $0.28 (up 817.86%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, L3 Technologies reported revenue of $9,573.00MM vs $9,210.00MM (up 3.94%) and analysts estimated basic earnings per share $8.68 vs $9.17 (down 5.34%). Analysts expect earnings to be released on January 24th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $2.35. The estimated EPS forecast for the next fiscal year is $11.51 and is expected to report on January 24th, 2019.

To read the full L3 Technologies Inc. (LLL) report, download it here: http://MarketSourceResearch.com/register/?so=LLL

-----------------------------------------

THE GOLDMAN SACHS GROUP, INC. (GS) REPORT OVERVIEW

The Goldman Sachs Group's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, The Goldman Sachs Group reported revenue of $8,646.00MM vs $8,326.00MM (up 3.84%) and analysts estimated basic earnings per share $6.35 vs $5.09 (up 24.75%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, The Goldman Sachs Group reported revenue of $32,073.00MM vs $30,608.00MM (up 4.79%) and analysts estimated basic earnings per share $9.12 vs $16.53 (down 44.83%). Analysts expect earnings to be released on January 16th, 2019. The report will be for the fiscal period ending December 31st, 2018. Based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $5.42. Reported EPS for the same quarter last year was $5.68. The estimated EPS forecast for the next fiscal year is $24.90 and is expected to report on January 16th, 2019.

To read the full The Goldman Sachs Group, Inc. (GS) report, download it here: http://MarketSourceResearch.com/register/?so=GS

-----------------------------------------

GENUINE PARTS COMPANY (GPC) REPORT OVERVIEW

Genuine Parts' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Genuine Parts reported revenue of $4,722.92MM vs $4,095.91MM (up 15.31%) and analysts estimated basic earnings per share $1.50 vs $1.08 (up 38.89%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Genuine Parts reported revenue of $16,308.80MM vs $15,339.71MM (up 6.32%) and analysts estimated basic earnings per share $4.19 vs $4.61 (down 9.11%). Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.12. The estimated EPS forecast for the next fiscal year is $6.00 and is expected to report on February 19th, 2019.

To read the full Genuine Parts Company (GPC) report, download it here: http://MarketSourceResearch.com/register/?so=GPC

-----------------------------------------

BRUKER CORPORATION (BRKR) REPORT OVERVIEW

Bruker's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Bruker reported revenue of $466.60MM vs $435.60MM (up 7.12%) and basic earnings per share $0.28 vs $0.23 (up 21.74%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Bruker reported revenue of $1,765.90MM vs $1,611.30MM (up 9.59%) and analysts estimated basic earnings per share $0.50 vs $0.95 (down 47.37%). Analysts expect earnings to be released on February 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.51. The estimated EPS forecast for the next fiscal year is $1.56 and is expected to report on February 14th, 2019.

To read the full Bruker Corporation (BRKR) report, download it here: http://MarketSourceResearch.com/register/?so=BRKR

-----------------------------------------

OMEROS CORPORATION (OMER) REPORT OVERVIEW

Omeros' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Omeros reported revenue of $4.61MM vs $21.66MM (down 78.72%) and analysts estimated basic earnings per share -$0.81 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Omeros reported revenue of $64.83MM vs $41.62MM (up 55.77%) and analysts estimated basic earnings per share -$1.17 vs -$1.65. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.25. The estimated EPS forecast for the next fiscal year is -$1.39 and is expected to report on March 7th, 2019.

To read the full Omeros Corporation (OMER) report, download it here: http://MarketSourceResearch.com/register/?so=OMER

-----------------------------------------

AIMMUNE THERAPEUTICS, INC. (AIMT) REPORT OVERVIEW

Aimmune Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.81. The estimated EPS forecast for the next fiscal year is -$3.52 and is expected to report on March 11th, 2019.

To read the full Aimmune Therapeutics, Inc. (AIMT) report, download it here: http://MarketSourceResearch.com/register/?so=AIMT

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: [email protected]

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc

ti?nf=NzQ3MjE0MCMyNjY4ODQyIzUwMDAzMTMyNg==

GlobeNewsWire
GlobeNewsWire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.